Citigroup Inc Ionis Pharmaceuticals Inc Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 76,618 shares of IONS stock, worth $3.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,618

Previous 222,943 65.63%

Holding current value

$3.09 Million

Previous $9.66 Million 62.22%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$36.45 - $47.7 $5.33 Million - $6.98 Million	-146,325 Reduced 65.63%	76,618 $3.65 Million
Q1 2024 May 10, 2024	BUY	$42.03 - $53.55 $5.16 Million - $6.57 Million	122,698 Added 122.4%	222,943 $9.66 Million
Q4 2023 Feb 09, 2024	SELL	$43.39 - $51.63 $3.88 Million - $4.61 Million	-89,375 Reduced 47.13%	100,245 $5.07 Million
Q3 2023 Nov 09, 2023	BUY	$38.5 - $47.13 $4.15 Million - $5.08 Million	107,873 Added 131.96%	189,620 $8.6 Million
Q2 2023 Aug 10, 2023	SELL	$34.73 - $43.33 $3.59 Million - $4.47 Million	-103,226 Reduced 55.81%	81,747 $3.35 Million
Q1 2023 May 11, 2023	BUY	$33.58 - $41.2 $1.88 Million - $2.3 Million	55,844 Added 43.25%	184,973 $6.61 Million
Q4 2022 Feb 09, 2023	SELL	$37.12 - $46.52 $1.78 Million - $2.23 Million	-47,863 Reduced 27.04%	129,129 $4.88 Million
Q3 2022 Nov 10, 2022	BUY	$36.54 - $48.66 $1.02 Million - $1.36 Million	27,861 Added 18.68%	176,992 $7.83 Million
Q2 2022 Aug 10, 2022	BUY	$31.71 - $43.0 $2.15 Million - $2.92 Million	67,795 Added 83.35%	149,131 $5.52 Million
Q1 2022 May 12, 2022	SELL	$29.88 - $37.04 $3.13 Million - $3.88 Million	-104,711 Reduced 56.28%	81,336 $3.01 Million
Q4 2021 Feb 10, 2022	BUY	$25.61 - $35.1 $1.66 Million - $2.28 Million	64,983 Added 53.68%	186,047 $5.66 Million
Q3 2021 Nov 10, 2021	BUY	$33.54 - $40.55 $4.06 Million - $4.91 Million	121,064 New	121,064 $4.06 Million

Others Institutions Holding IONS

# of Institutions

389

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.73B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account